betaSense GmbH identifies new diagnostic biomarker for Parkinson’s - European Biotechnology Magazine
Summary by European-biotechnology.com
3 Articles
3 Articles
All
Left
Center
Right
betaSense GmbH identifies new diagnostic biomarker for Parkinson’s - European Biotechnology Magazine
A new biomarker for Parkinson's disease makes it possible to recognise and treat the hereditary dopamine deficiency before the mid-brain is damaged, reports University Bochum spin-out betaSense GmbH. The post betaSense GmbH identifies new diagnostic biomarker for Parkinson’s appeared first on European Biotechnology Magazine.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage